ME-143, a second-generation tumor-specific NADH oxidase inhibitor, exhibits efficacy by inhibiting the WNT/beta-catenin pathway in colorectal cancer cells. Demonstrating broad activity against cancers both in vitro and in vivo, this compound presents a promising therapeutic avenue.
Molekulargewicht:
334.37
CAS Nummer:
[852536-39-1]
Formel:
C21H18O4
Target-Kategorie:
Endogenous Metabolite|||Others|||Wnt/beta-catenin
T73478
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten